ICAM1 and systemic sclerosis: In particular, circulating levels of ICAM-1 were found to be significantly higher in SSc patients with DUs compared to those without [29], while elevated serum levels of VCAM-1 were not predictive for the occurrence of new DUs in SSc [30] and showed no association with NVC patterns [31].